Description
ACECLOFENACO 100
Insuficiencia cardiaca congestiva (clasificación II-IV de la NYHA)
PRINCIPIO ACTIVO: ROSUVASTATINA
El SOFIA2 utiliza tecnología de inmunofluorescencia lateral para detectar antígenos y biomarcadores específicos
SUBSAL DE BISMU 262MG 24TAB LGEN FLUNARIZINA ACECLOFENACO 100PRINCIPIO ACTIVO: SUBSALICILATO DE BISMUTO DOSIS: 262 MG FORMA FARMACUTICA: 24 TABLETA MASTICABLE PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
